Novavax applies to WHO for emergency listing of COVID-19 vaccine

Novavax Inc and its partner Serum Institute of India have applied to the World Health Organization for an emergency use listing of Novavax's COVID-19 vaccine, the company said on Thursday.

The WHO's emergency use listing is a signal to national regulatory authorities on a product's safety and efficacy.